Herpes Simplex Virus: A Nutritional and Natural-Health Reference
Definition and Overview
Herpes simplex virus (HSV) is a double-stranded, lipid-enveloped DNA virus and a member of the Alphaherpesvirinae subfamily of the Herpesviridae family of viruses. HSV is classified into two subtypes, HSV-1 and HSV-2. HSV-1 is primarily responsible for orolabial infections, while HSV-2 is more prevalent in anogenital infections. In recent years, adolescents and younger patients are increasingly experiencing HSV-1 infection in the anogenital area as a result of changing sexual behaviors.
Herpes simplex viruses, HSV-1 and HSV-2, are highly contagious and cause lifelong, latent infections with recurrent outbreaks of oral and/or genital lesions. No cure exists for HSV-1 or HSV-2 infections, but antiviral medications are commonly used to prevent and treat outbreaks.
Global Epidemiology
In 2016, an estimated 491.5 million people (95% uncertainty interval: 430.4–610.6 million) were living with HSV-2 infection, equivalent to 13.2% of the world's population aged 15–49 years. An estimated 3,752.0 million people had HSV-1 infection at any site, equivalent to a global prevalence of 66.6% in 0–49-year-olds. Differing patterns were observed by age, sex, and geographical region, with HSV-2 prevalence being highest among women and in the WHO African Region.
According to 2024 WHO estimates, around 846 million people aged between 15 and 49 are living with genital herpes infections — more than 1 in 5 of this age group globally. While the 2020 estimates show virtually no difference in the prevalence of genital HSV-2 compared to 2016, estimated genital HSV-1 infections are higher. Over recent years, several countries have observed changing patterns of transmission in HSV-1, with adult genital infections increasing as childhood oral infections decline.
In the United States, up to 80% of people between the ages of 14 and 49 are infected with HSV-1, and more than 10% are infected with HSV-2.
Pathophysiology: How the Virus Behaves in the Body
Initial Infection and Tissue Involvement
At the contact site, HSV-1 primary infections are initiated after penetration of the tissue by the viruses and fusion of the viral envelope with the epidermal and dermal skin membranes. Infection of the skin or mucosa is accompanied by inflammation and tissue damage, causing the characteristic herpes blisters. During initial infection, the virus is spread by direct skin-to-skin contact with an open lesion or an infected individual. Infection can still occur after contact with asymptomatic infected individuals.
Viral infection induces ballooning of cells with condensed chromatin within the nuclei, followed by nuclear degeneration, generally within parabasal and intermediate cells of the epithelium. Cells lose intact plasma membranes and form multinucleated giant cells. With cell lysis, a clear (vesicular) fluid containing large quantities of virus appears between the epidermis and dermal layer. The vesicular fluid contains cell debris, inflammatory cells, and often multinucleated giant cells.
Neurotropism and Latency
Following efficient replication in epithelial cells, HSV reaches nerve endings of peripheral neurons and undergoes retrograde transport to the neuronal cell body. Alphaherpesviruses characteristically establish latent infection in sensory nerve ganglia. Like all herpesviruses, HSV has two replication cycles: lytic and latent. During lytic replication HSV produces infectious viral particles to infect other cells and organisms, while during latency there is limited gene expression and lack of infectious virus particles.
As acute infection in the periphery resolves, patients become asymptomatic but retain HSV-1 inside latently infected sensory neurons, which provide a reservoir for future reactivation. Reactivation is often triggered by external and internal stress stimuli that induce the release of HSV-1 from the trigeminal ganglion and recurrence of acute infection at the initial transmission site.
Body Systems Involved
Herpes simplex viruses cause a variety of peripheral and CNS illnesses of infectious and post-infectious nature. The major organ systems implicated include:
- Integumentary system: Infection with HSV can cause pain and blistering within the mouth (gingivostomatitis or recurrent oral ulceration) or on or around the lips (cold sores or herpes labialis).
- Nervous system: HSV-1 is the most common cause of sporadic severe encephalitis in the United States, accounting for an estimated 10 to 20% of all cases.
- Immune system: Due to the breach of the immune system, the host cell's retaliation to viral suppression is disrupted, consequently evading immune responses — a process involving what is known as "virion host shutoff."
- Reproductive system: Adolescent and adult infection with HSV-2 may present as painful genital ulcers. Neonatal infection carries high morbidity and mortality.
Reactivation from latent infection and subsequent replication of the virus can cause substantial disease including oral and genital ulcers, herpes keratitis, and encephalitis. In addition, multiple studies have linked persistent HSV-1 infection to the progression of Alzheimer's disease.
Clinical Presentation
Systemic symptoms of primary infection can include fever, malaise, lymphadenopathy, and multiple ulcers. Gingivostomatitis is the most common presentation in young children. It presents with vesicles and ulcers on the tongue, lips, gums, buccal mucosa, and hard and soft palates.
Recurrence of labial HSV is typically triggered by factors such as stress, trauma from surgery, menstruation or hormonal shifts in women, hyperthermia or infectious febrile ailments, sunlight or ultraviolet rays, and certain drugs, such as corticosteroids, with substantial psychosocial consequences to patients enduring persistent outbreaks. The regularity of these recurrent outbreaks varies from one individual to another; the infection is generally contagious during times of active replication, but can also spread when symptoms are absent.
Contributing and Associated Factors
Established Reactivation Triggers
Conditions that can reactivate HSV include physiological and psychological stress, fatigue, ultraviolet irradiation, physical trauma, abnormal hormone levels, immunosuppression, menstruation, fever, and upper respiratory tract infections.
Numerous studies have concluded that stress — whether acute, episodic acute, or chronic — increases the incidence of HSV-1 reactivation from latency in neurons. Psychosocial stress is a significant risk factor for HSV recurrence. Depressive symptoms increase the risk of an outbreak, and Cognitive Behavioral Therapy has been found to improve markers indicative of recurrence.
Latent HSV-1 in neurons of various ganglia can be reactivated by local injury to tissues innervated by latently infected neurons, or by systemic physical or emotional stress, fever and microbial co-infection, UV exposure, or hormonal imbalance.
Immunological Factors
The fact that certain individuals are more prone than others to suffer severe disease upon HSV infection can be partially explained by the existence of genetic polymorphisms in humans. After infecting their hosts, herpesviruses cannot be eradicated; instead, they establish latency and persist for life. As the host's immunity declines, these viruses can reactivate to induce various symptoms.
IL-1β is released under conditions of stress, fever, and UV exposure of the epidermis — all known triggers of clinical HSV reactivation. IL-1β has been found to induce histone phosphorylation and increase the excitation in sympathetic neurons. Importantly, IL-1β triggered HSV-1 reactivation in a mechanism dependent on neuronal excitability.
Nutritional Deficiency as a Contributing Factor
HSV-1 causes recurrent oral lesions with reactivation triggered by factors such as stress, hormones, and nutrition. Immune suppression caused by these factors plays an important role in HSV-1 reactivation and requires comprehensive management. RIH infection could be reactivated by various factors, including stress, immunosuppressants, hormonal influences, sunlight exposure, or vitamin D deficiency.
Nutrients, Herbs, and Natural Ingredients
1. L-Lysine
Traditional Use
L-lysine supplementation for herpes began as a nutritional intervention in alternative and integrative medicine practice. A daily dose of 50 mg/kg of body weight has previously been recommended for cold sores but is not often advised by doctors due to conflicting evidence. The first studies with these amino acids date back to the 1960s, when it was inferred that, in vitro, lysine could suppress the expression of viruses such as adenovirus and herpes simplex virus.
Proposed Mechanism
Based on tissue culture studies, it is thought that lysine-arginine balance may affect HSV expression. Arginine-rich proteins are required for reproduction of HSV, whereas lysine competitively inhibits their synthesis. Lysine is an amino acid that can interfere mainly in the formation of capsid proteins and DNA by a competitive antagonism with arginine, which is an essential amino acid for some viruses, and also by promoting the increase of arginase, increasing the catabolism of arginine.
Scientific Evidence
Lysine-arginine balance is thought to affect HSV expression. Oral lysine has been investigated in the prevention of HSV recurrence. Trials have yielded mixed results. A 2017 evidence review published in PMC concluded: L-lysine supplementation appears to be ineffective for prophylaxis or treatment of herpes simplex lesions with doses of less than 1 g/day without low-arginine diets. Doses in excess of 3 g/day appear to improve patients' subjective experience of the disease. Longer duration controlled studies of daily lysine doses exceeding 1.2 g/day are required to definitively test its role in herpes simplex prophylaxis.
Regarding dietary context, a study from the University of California, San Diego found: Dietary intake of the amino acids lysine and arginine did not differ significantly between normal controls and patients with herpes virus. Both groups of subjects consumed significantly more lysine than arginine on a daily basis. The investigators noted that there is large variability in the intake of both amino acids and the ratios in individual diets, and more rigorous monitoring of dietary intake is essential for future studies.
Evidence strength: Although non-pharmaceutical approaches beginning with nutrient supplementation such as zinc, vitamin C, vitamin D, lysine, and low-arginine diets have some potential benefits in the management of HSV-1 infections, results were mostly inconsistent and unreliable. Overall, the clinical evidence for lysine is mixed and limited by small sample sizes and study design issues.
2. Zinc
Traditional Use
Topical and systemic administration of zinc compounds has long been indicated to have preventive and therapeutic effects in recurrent herpes labialis. Zinc compounds have been used topically in folk and naturopathic traditions for skin conditions including herpetic lesions.
Scientific Evidence
Using a standard plaque assay and clinical isolates of HSV, researchers tested the ability of zinc salts to inactivate HSV. Of 10 randomly chosen clinical isolates (five HSV-1 and five HSV-2), seven were inactivated >98% by treatment in vitro with 50 mM zinc gluconate for 2 hours, and nine were inactivated >97% by treatment with zinc lactate. The effect was concentration dependent.
In human trials, in 46 participants with facial or circumoral herpes, 21-day application of a zinc oxide/glycine cream significantly reduced the duration of cold sores and severity of symptoms (blistering, soreness, itching, tingling) compared to a placebo cream. In a separate study of herpes genitalis, only 1% of patients (receiving 4% zinc sulfate in distilled water) and 6% of patients (receiving 2% zinc sulfate) recurred after a six-month treatment, compared to 80% of those given a distilled water control; moreover, no side effects were observed.
Clinical trials for determination of the effectiveness of zinc in the treatment of herpes simplex virus disease have yielded inconsistent or inconclusive results. Evidence strength: In vitro evidence is robust; topical clinical evidence is preliminary and based on small trials. Oral zinc supplementation data for HSV specifically are limited.
3. Vitamin D
Traditional and Theoretical Context
Vitamin D is a family of lipid-soluble steroid hormones synthesized in the lower epidermis through a photochemical reaction with ultraviolet (UVB) light, while dietary sources include milk and various types of fish. HSV reactivation is associated with vitamin D deficiency as a contributing factor.
Scientific Evidence
A cell study indicated that cathelicidin — an antimicrobial peptide associated with vitamin D signaling — decreased HSV-1 viral titres isolated from patients with keratoconjunctivitis; furthermore, another cell study also showed that vitamin D supplementation reduced HSV-1 viral load and mRNA expression in HSV-1-infected cells.
A systematic review and meta-analysis of 10 studies (all conducted among immunosuppressed patients) concluded: There was no evidence that vitamin D deficiency is associated with cytomegalovirus (CMV) disease, herpes zoster after transplantation, or HHV-8 among HIV patients. Vitamin D supplementation may decrease herpes zoster among hemodialysis patients (1 study) or CMV disease after renal transplantation (1 study), but supplementation was not associated with reduced EBV viral load among multiple sclerosis patients. Any association between vitamin D and herpesviruses remains inconclusive.
A more focused 2025 PMC review noted: No clear evidence of the protective effects of vitamin D supplements in herpes simplex infections has been observed, and further studies are needed.
Evidence strength: Preliminary and inconclusive for HSV specifically. Mechanistic cell data are promising, but controlled clinical trials in immunocompetent populations are lacking.
4. Vitamin C (Ascorbic Acid)
Traditional Use
Vitamin C has a long history of use in traditional and naturopathic medicine for immune support and wound healing. Its application to herpetic lesions has been described in clinical integrative contexts as both topical and oral.
Scientific Evidence
Both oral consumption and topical application of vitamin C have been reported to increase the rate of healing of herpetic ulcers. In a randomized double-blind study, an ascorbic acid–containing pharmaceutical formulation (Ascoxal) applied with a soaked cotton wool pad three times daily for 2 minutes resulted in patients reporting fewer days with scabs and fewer cases of worsening of symptoms.
In another study, 20 patients with herpes labialis were treated with a complex of 1,000 mg water-soluble bioflavonoids and 1,000 mg of vitamin C in equal increments five times daily. The water-soluble bioflavonoid–vitamin C complex was shown to reduce vesiculation and to prevent disruption of the vesicular membrane. The therapy was most beneficial when initiated at the beginning of the disease.
Among natural remedies for HSV, only the use of Melissa officinalis, tea tree oil, topical zinc, sage-rhubarb cream, and vitamin C is supported by clinical trials; however, in most cases there are trials that present only preliminary data, with few confirming trials and generally no direct comparison to acyclovir.
Evidence strength: Preliminary; small trials only, with some positive signals for topical use and oral bioflavonoid-vitamin C combinations. Larger, well-designed RCTs are absent.
5. Lemon Balm (Melissa officinalis)
Traditional Use
Traditionally, Melissa officinalis (lemon balm) has been used as a carminative for gastrointestinal distress, including flatulence and colic, or as a mild sedative. The Greeks and Romans used lemon balm for wound dressings and to treat bites and stings. In folk medicine it is used for nervous complaints, lower abdominal disorders, and — more recently — for treating herpes simplex lesions.
Phytochemistry
Melissa officinalis leaves have a range of chemical constituents; of primary importance are the tannins, polyphenols, glycosides, and rosmarinic acid. Early work with tannin and polyphenol components demonstrated activity against numerous viruses, including herpes simplex. Later investigations attribute antiviral effects more specifically to phenolcarboxylic acid.
Scientific Evidence
In vitro: Melissa officinalis essential oil was phytochemically examined; its main constituents were identified as monoterpene aldehydes citral a, citral b, and citronellal. At noncytotoxic concentrations of the oil, plaque formation was significantly reduced by 98.8% for HSV-1 and 97.2% for HSV-2; higher concentrations of lemon balm oil abolished viral infectivity nearly completely. A Melissa extract was found to be 80% and 96% inhibitory, respectively, of cellular attachment by acyclovir-sensitive and acyclovir-resistant HSV-1 strains.
Clinical trials: In a double-blind study of 66 patients with recurrent herpes labialis, a lemon balm cream (leaf extract) significantly reduced symptom scores (in blistered areas) after two days of treatment compared to a placebo cream. Likewise, in another randomized, double-blind study of 116 patients, lemon balm application initiated within 72 hours of symptom onset, two to four times daily for ten days, produced significant results.
Major trial limitations include inadequate enrollment to meet power and overstated conclusions given the results presented. There is question as to whether the statistically significant difference between groups on day 2 is actually clinically significant.
Evidence strength: In vitro evidence is strong. Human clinical data are promising but preliminary — limited to small-to-medium trials with methodological limitations, topical applications only.
6. Propolis
Traditional Use
Propolis is a resinous substance produced by bees from plant exudates and has been used in traditional medicine across many cultures for its antimicrobial and wound-healing properties. Its application to herpetic lesions has been documented in naturopathic and integrative medicine traditions.
Phytochemistry and In-Vitro Evidence
As an antiviral agent, propolis and various constituents have shown promising preclinical efficacy against adenoviruses, influenza viruses, herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2), and other pathogens. Over 300 chemical components have been identified in propolis, including terpenes, flavonoids, and phenolic acids, with the specific constituent profile varying widely according to geographic origin and regional flora.
Both aqueous and ethanolic propolis extracts exhibited high levels of antiviral activity against HSV-2 in viral suspension tests; infectivity was significantly reduced by >99%, and a direct concentration- and time-dependent antiherpetic activity was demonstrated for both extracts.
Scientific Evidence — Clinical
A 2026 meta-analysis (7 studies included) found: Treatment with propolis and/or honey was associated with quicker lesion resolution (mean difference: −1.87 days; 95% CI: −2.73 to −1.01; p < 0.0001) and higher healing rates by day 7 (OR: 4.71; 95% CI: 2.70–8.25; p < 0.00001). No significant difference was observed in the number of aborted attacks. Propolis and/or honey also reported reduced pain duration and pain intensity, with more patients reporting being symptom-free by day 3.
An earlier systematic review with meta-analysis (2017) concluded: In one study on genital diseases, external use of propolis showed significant differences in genital herpes outcome measures compared to placebo. However, overall results on the effectiveness of external propolis for treating oral, skin, and genital diseases are not conclusive because of the low methodological qualities and small sample sizes.
Bee propolis as lip balms was proposed as an alternative to topical antiviral applications; one study confirmed its superiority and safety when used in cases where standard antivirals were not profoundly tolerated.
Evidence strength: Moderate for topical use, based on several small-to-medium RCTs. The 2026 meta-analysis provides the most comprehensive synthesis to date; however, methodological heterogeneity limits strong conclusions. No evidence for oral propolis against HSV specifically.
7. Other Herbs and Natural Agents Mentioned in the Literature
A comprehensive review identified the following agents as discussed — though not all are supported by clinical trial evidence — in the natural management of herpes simplex: L-lysine, lemon balm (Melissa officinalis), aloe vera extract, astragalus, bee propolis, elderberry, echinacea, cat's claw, sage-rhubarb, sandalwood, tea tree oil, and witch hazel.
- Aloe Vera: The rising trend of drug resistance in HSV infections has prompted investigation of Aloe vera as an alternative. An in silico study identified several Aloe vera compounds, including triterpenoid and campesterol, that exhibit high affinity for key HSV proteins, suggesting their potential as novel candidates for further laboratory and clinical investigations. Clinical evidence remains very limited.
- Echinacea: In a 5-month uncontrolled clinical study of 4,598 patients, a salve prepared from the juice of the aerial portion of Echinacea purpurea was reported to have an 85% success rate in the treatment of a number of inflammatory skin conditions, including herpes simplex eruptions. Echinacea is commonly used as a tincture or decoction as part of a protocol for HSV infection. However, this was uncontrolled and cannot be considered strong evidence.
- Sage-Rhubarb Cream: Among natural remedies proposed for HSV, clinical trial support exists for topical sage-rhubarb cream, though trials generally present only preliminary data with few confirming studies.
- Kanuka Honey: An open-label RCT using medical-grade kanuka honey highlighted that botanical compounds can be an alternative to acyclovir with a better safety profile for HSV labialis.
Dietary Factors
The Arginine-to-Lysine Ratio
The ratio of dietary arginine to lysine has been discussed in the literature as potentially relevant to HSV recurrence. The American population's preference for high-lysine foods, such as meat and dairy products, as opposed to foods high in arginine, such as legumes, whole grains, and nuts, is relevant to this discussion. The higher the arginine/lysine ratio in any diet, the greater the reported risk for herpes recurrence. Patients with diets high in naturally occurring arginine, such as legumes, whole grains, and nuts, are considered more vulnerable to herpes simplex recurrence than those whose diets are high in lysine, such as meat and dairy products.
It should be noted, however, that the clinical evidence supporting dietary arginine restriction as an effective intervention for HSV is indirect and based on mechanistic reasoning rather than well-controlled dietary trials. The extent of variability in total amino acid intake and in the ratio of lysine to arginine in individual diets remains poorly quantified, and the possible effects of these ranges on study results are unknown. In order for future studies to accurately determine the effects of supplemental lysine in the treatment of herpes infections, close monitoring of dietary intake is essential.
Nutritional Deficiency
HSV-1 reactivation is triggered by factors including nutrition. Immune suppression caused by nutritional factors plays an important role in HSV-1 reactivation and requires comprehensive management. Specific micronutrient deficiencies — including vitamin D — have been discussed as contributing to immune dysregulation that may permit HSV reactivation, though the clinical evidence remains preliminary.
Lifestyle Factors
Stress and Psychological Factors
Numerous studies have concluded that stress — whether acute, episodic acute, or chronic — increases the incidence of HSV-1 reactivation from latency in neurons. Psychosocial stress is a significant risk factor for HSV recurrence. Depressive symptoms increase the risk of an outbreak and Cognitive Behavioral Therapy has been found to improve markers indicative of recurrence.
Sleep
Sleep strengthens the immune response; most immune cells' response to challenges (e.g., viral infections) peaks at night. Adequate sleep appears to be about 7–8 hours per night. Direct studies connecting sleep deprivation to HSV recurrence rate are not yet available in the peer-reviewed literature.
UV Light Exposure
Stimuli in humans linked with clinical HSV-1 reactivation include exposure to UV light, psychological stress, fever, and changes in hormone levels. Minimizing sun exposure to the face and using sunscreen on the lips has been discussed as a practical measure in integrative health contexts.
Hormonal Fluctuations
Menstruation and hormonal shifts in women are recognized triggers of recurrent herpes labialis, alongside stress, fever, sunlight, and corticosteroids. These fluctuations likely act via immunomodulatory pathways that permit viral reactivation.
Body Weight
Obesity may increase susceptibility to HSV-1 infection, though the evidence base for this specific association requires further investigation.
Evidence Summary Table
- L-Lysine (oral): Mixed RCT evidence; some benefit at doses >1 g/day; systematic reviews are inconclusive. Small trials, variable dietary controls.
- Zinc (topical): Positive signals in small RCTs for reduced duration and severity. In vitro evidence robust. Clinical evidence preliminary.
- Zinc (oral): Data for HSV specifically are very limited.
- Vitamin C (topical and oral): Preliminary RCT evidence for wound healing and vesicle reduction; combined bioflavonoid-vitamin C shows promise in small trials.
- Vitamin D: Cell-level mechanisms identified; systematic review of clinical trials (mainly in immunosuppressed patients) remains inconclusive for HSV specifically.
- Lemon Balm (topical): In vitro evidence strong; two small-to-medium RCTs show symptom benefit. Preliminary clinical evidence.
- Propolis (topical): 2026 meta-analysis (7 RCTs) shows faster healing vs. acyclovir cream. Moderate evidence, though methodological heterogeneity is a limitation.
- Echinacea, Aloe Vera, Sage-Rhubarb, Elderberry: Traditional use documented; clinical evidence very limited or absent for HSV.
References
Go back